JP2021529195A5 - - Google Patents
Info
- Publication number
- JP2021529195A5 JP2021529195A5 JP2020572815A JP2020572815A JP2021529195A5 JP 2021529195 A5 JP2021529195 A5 JP 2021529195A5 JP 2020572815 A JP2020572815 A JP 2020572815A JP 2020572815 A JP2020572815 A JP 2020572815A JP 2021529195 A5 JP2021529195 A5 JP 2021529195A5
- Authority
- JP
- Japan
- Prior art keywords
- total weight
- pharmaceutical composition
- acid
- composition according
- mannurondioc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810721276.7 | 2018-06-29 | ||
| CN201810721276.7A CN110652525A (zh) | 2018-06-29 | 2018-06-29 | 甘露糖醛二酸的组合物在治疗炎症中的应用 |
| PCT/CN2019/093656 WO2020001611A1 (zh) | 2018-06-29 | 2019-06-28 | 甘露糖醛二酸的组合物在治疗炎症中的应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021529195A JP2021529195A (ja) | 2021-10-28 |
| JP2021529195A5 true JP2021529195A5 (https=) | 2022-07-04 |
Family
ID=68985392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020572815A Pending JP2021529195A (ja) | 2018-06-29 | 2019-06-28 | 炎症の治療におけるマンヌロン二酸組成物の使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11406659B2 (https=) |
| EP (1) | EP3815693A4 (https=) |
| JP (1) | JP2021529195A (https=) |
| KR (1) | KR20210040041A (https=) |
| CN (1) | CN110652525A (https=) |
| AU (1) | AU2019296419A1 (https=) |
| WO (1) | WO2020001611A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112336742A (zh) * | 2019-08-06 | 2021-02-09 | 上海绿谷制药有限公司 | 甘露糖醛酸寡糖治疗Th1主导相关疾病的用途 |
| WO2025245773A1 (zh) * | 2024-05-30 | 2025-12-04 | 海糖（江苏）生物医药科技有限公司 | 一种褐藻寡糖衍生物及其制备方法和用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1562050A (zh) * | 2004-03-24 | 2005-01-12 | 中国海洋大学 | 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用 |
| JPWO2007069468A1 (ja) * | 2005-12-14 | 2009-05-21 | 国立大学法人 長崎大学 | サイトカイン分泌促進剤 |
| JP2016108474A (ja) * | 2014-12-08 | 2016-06-20 | 栄治 松村 | オリゴ糖の製造方法およびオリゴ糖 |
| CN106344594A (zh) * | 2015-07-17 | 2017-01-25 | 上海绿谷制药有限公司 | 褐藻胶寡糖及其衍生物在治疗炎症中的应用 |
| CN106344595B (zh) | 2015-07-17 | 2020-06-19 | 上海绿谷制药有限公司 | 褐藻胶寡糖及其衍生物在制备治疗疼痛药物中的应用 |
| CN106344592A (zh) | 2015-07-17 | 2017-01-25 | 上海绿谷制药有限公司 | 还原端1位为羧基的甘露糖醛酸寡糖及其衍生物在治疗帕金森氏症中的应用 |
| DE102016113018A1 (de) * | 2016-07-14 | 2018-01-18 | Abbas Mirshafiey | Pharmazeutische Verwendung von beta-D-Mannuronsäure |
| JP6846509B2 (ja) * | 2016-08-15 | 2021-03-24 | 上海緑谷製薬有限公司Ｓｈａｎｇｈａｉ Ｇｒｅｅｎ Ｖａｌｌｅｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． | オリゴマンヌロン二酸の製造方法 |
| AU2017385332B2 (en) * | 2016-12-30 | 2020-10-29 | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Composition of mannuronic dicarboxylic acid |
-
2018
- 2018-06-29 CN CN201810721276.7A patent/CN110652525A/zh active Pending
-
2019
- 2019-06-28 AU AU2019296419A patent/AU2019296419A1/en not_active Abandoned
- 2019-06-28 JP JP2020572815A patent/JP2021529195A/ja active Pending
- 2019-06-28 WO PCT/CN2019/093656 patent/WO2020001611A1/zh not_active Ceased
- 2019-06-28 US US17/256,854 patent/US11406659B2/en active Active
- 2019-06-28 EP EP19825915.2A patent/EP3815693A4/en not_active Withdrawn
- 2019-06-28 KR KR1020217001707A patent/KR20210040041A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018193377A5 (https=) | ||
| JP5177446B2 (ja) | 低粘度グリコサミノグリカンで構成される組成物及び該組成物の間質性膀胱炎の治療での使用 | |
| JP2021529195A5 (https=) | ||
| ATE511847T1 (de) | Pharmazeutische zubereitung für die behandlung entzündlicher erkrankungen des urogenitaltraktes | |
| CA2449962A1 (en) | Use of glycosaminoglycans for the treatment of hiv-associated nephropathy | |
| CN103230362A (zh) | 氟尼辛葡甲胺注射用原位凝胶及其制备方法 | |
| JP2009532359A5 (https=) | ||
| JP6850883B2 (ja) | 乾癬及び尋常性白斑の治療薬の製造のための、メチル４−［９−（６−アミノプリニル）］−２（ｓ）−ヒドロキシブチラートの使用。 | |
| JP2014533701A5 (https=) | ||
| JP2022503733A5 (https=) | ||
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| JP2021528460A5 (https=) | ||
| JP2021528459A5 (https=) | ||
| EP2814848B1 (en) | Partially depolymerized glycosaminoglycan silver and gold salts | |
| EP1539192A1 (en) | Composition and kit for the treatment of inflammatory bowel diseases | |
| JP2012526099A5 (https=) | ||
| WO2026011995A1 (zh) | 癸酸单甘油酯在制备降血糖的药物或功能食品中的应用 | |
| JP2002539233A (ja) | リウマチ障害を一般投与によって予防または治療するための、コンドロイチン硫酸およびキトサンに基づく組成物 | |
| JP2021528458A5 (https=) | ||
| JP3472442B2 (ja) | 損傷皮膚修復用製剤 | |
| JP2014521606A (ja) | 眼表面アレルギーの処置のための組成物および方法 | |
| JP2000038342A (ja) | 褥瘡・損傷皮膚修復用製剤 | |
| CN115919753A (zh) | 一种活血止痛凝胶及其制备方法 | |
| JP2021529196A5 (https=) | ||
| WO2006067502A1 (en) | Treatment of inflammatory diseases |